Trade Names: | |
Synonyms: | |
Status: | Approved (2002) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | 3X6SAX83JZ |
Parent Compound: | ZIPRASIDONE |
InChI Key | LOQSYPGSAZUDJZ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C22H31ClN4O7S2 |
Molecular Weight | 563.1 |
AlogP | 3.81 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 48.47 |
Molecular species | NEUTRAL |
Aromatic Rings | 3.0 |
Heavy Atoms | 28.0 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Dopamine D2 receptor antagonist | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Schizophrenia | 3 | D012559 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 53757 |
ChEMBL | CHEMBL3989833 |
FDA SRS | 3X6SAX83JZ |
PubChem | 656685 |
SureChEMBL | SCHEMBL957178 |